Notice of Intent to Sole Source -CoStar

Added: Sep 02, 2015 10:04 am INTENT TO SOLE SOURCE- CoStar Real Estate Database access

September 1, 2015

NAICS Code - 541511 - Custom Computer Programming Services.

Synopsis: The U.S. Food and Drug Administration (FDA) intends to award solely under the authority of 10 USC 2304 (c) (1)-only one responsible source to CoStar, 1331 L St, NW, Washington DC. 20005-4101. This procurement is for CoStar database access for 2 authorized users. The government will purchase the following items:

CoStar Reality Database access for 1 year plus 4 option years.

This database access will provide FDA access to the following CoStar programs:

• CoStar Property Professional
• CoStar Professional Directory
• Co-Star COMPS Professional
• CoStar Portfolio Strategy

CoStar's database solutions are unique in the industry in that they are (1) fully researched and verified by over 1,200 fully-trained, highly quality-controlled research analysts and interpreted by 75 real estate economists; (2) Full Inventory databases that include properties in major metropolitan areas and also suburban and rural areas too; (3) pro-actively updated on a regular (30-90 day) cycle.

This is a Notice of Intent to issue an award on a sole source basis. This announcement constitutes the only notice by the government; a written solicitation will not be issued. All sources that believe they are eligible to provide these items must respond in writing. Responses must be supported with clear and convincing evidence to clearly articulate the ability to provide the items outlined above.

This Special Notice of Intent is not a request for competitive quotes. Information received will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. If no written responses are received by the date listed below, which reflects fifteen (15) days after the publication of this notice, the purchase will be awarded without further remark. All questions and responses concerning this notice shall be emailed to Ms. Lisa Jackson at lisa.jackson@fda.hhs.gov. A determination by the government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. The projected award date is on or about September 11, 2015.

Contracting Office:
U.S. Food and Drug Administration
5630 Fishers Lane
Rockville MD 20857

Point of Contact:
Lisa Jackson
Email: lisa.jackson@fda.hhs.gov